Evidence map›Paper›PMID 42883335›Full record

ArticleMolecules (Basel, Switzerland)2026

Synthesis, Characterization and Biological Activity of Alkyl 3-(

Sergey V Andreev, Ekaterina I Anosova, Alisa P Terskova, Varvara A Morenova, Evita A Kostenko, Sergey A Zverev, Andrey S Kuzovlev

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sergey V AndreevDisinfectology Institute of F.F. Erisman FSCH of Rospotrebnadzor, 18a Nauchny Proezd, Moscow 117246, Russia.ORCID 0000-0003-2405-9931
Ekaterina I AnosovaDisinfectology Institute of F.F. Erisman FSCH of Rospotrebnadzor, 18a Nauchny Proezd, Moscow 117246, Russia.
Alisa P TerskovaDisinfectology Institute of F.F. Erisman FSCH of Rospotrebnadzor, 18a Nauchny Proezd, Moscow 117246, Russia.
Varvara A MorenovaDisinfectology Institute of F.F. Erisman FSCH of Rospotrebnadzor, 18a Nauchny Proezd, Moscow 117246, Russia.ORCID 0009-0007-8681-9509
Evita A KostenkoDisinfectology Institute of F.F. Erisman FSCH of Rospotrebnadzor, 18a Nauchny Proezd, Moscow 117246, Russia.
Sergey A ZverevDisinfectology Institute of F.F. Erisman FSCH of Rospotrebnadzor, 18a Nauchny Proezd, Moscow 117246, Russia.
Andrey S KuzovlevDisinfectology Institute of F.F. Erisman FSCH of Rospotrebnadzor, 18a Nauchny Proezd, Moscow 117246, Russia.ORCID 0000-0002-4952-3561

Funding

Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing 126030218221-8
6 · The paper itself

Abstract

Chemicals are widely used to protect humans from biological threats. Ticks are among the most dangerous biological species, as they transmit dangerous diseases such as Q-fever, Crimean-Congo hemorrhagic fever, tick-borne encephalitis, and others. It is not feasible nor viable to eradicate all tick populations in areas where people spend their leisure time or work. Personal protective equipment in general, and repellents in particular, have therefore become an important means of protection against this biological threat. Previous studies have shown that despite the repellent activity of substances currently used for this purpose, their effective concentrations against the taiga tick are not fit for practical application. In this study, we synthesized a homologous series of alkyl 3-(

Indexed as

AcaricidesIxodesIxodidaePropionatesAnimalsMolecular StructureAcaricidesPropionatesalkyl 3-(N-butylacetamido)propanoatesIR3535®, biological activityixodid ticksrepellenttaiga ticks

Identifiers

PMID42883335
PMCPMC13666575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.